The microglial-motoneuron dialogue in ALS - PubMed (original) (raw)

Review

The microglial-motoneuron dialogue in ALS

S H Appel et al. Acta Myol. 2011 Jun.

Abstract

Neuroinflammation is a pathological hallmark of neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), and is characterized by activated microglia at sites of neuronal injury. In ALS, neurons do not die alone; neuronal injury is noncell-autonomous and depends upon a well-orchestrated dialogue between motor neurons and microglia. Evidence from transgenic models expressing mutant superoxide dismutase 1 (SOD) suggests that the dialogue between motor neurons and microglia initially protects motor neurons. However, with increasing stress and injury within motor neurons, induced by the presence of misfolded proteins such as mSOD1, mitochondrial function and axoplasmic flow are impaired and endoplasmic reticulum stress is induced; misfolded proteins themselves or alternate signals are released from motor neurons and activate microglia. Activated microglia, in turn, switch from anti-inflammatory and neuroprotective to proinflammatory and neurotoxic. Neurotoxic signaling from motor neurons promotes microglial release of reactive oxygen species and pro-inflammatory cytokines further enhancing motor neuron stress and cell injury and initiating a self-propagating cycle of motor neuron injury and cell death. A greater understanding of how to restore the imbalance between neuroprotection and cytotoxicity will depend upon a greater understanding of the motor neuron-microglial dialogue.

PubMed Disclaimer

Figures

Figure 1.

Figure 1.

Microglia- Innate immune Cells of the CNS help mediate the balance between neuroprotection and cytotoxicity.

Figure 2.

Figure 2.

Major themes in ALS pathogenesis.

Similar articles

Cited by

References

    1. Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772–1775. - PubMed
    1. Henkel JS, Engelhardt JI, Siklos L, et al. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol. 2004;55:221–223. - PubMed
    1. Henkel JS, Beers DR, Siklós L, et al. The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol Cell Neurosci. 2006;31:427–437. - PubMed
    1. Clement AM, Nguyen MD, Roberts EA, et al. Wild-type noneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003;302:113–117. - PubMed
    1. Cardona AE, Pioro EP, Sasse ME, et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci. 2006;9:917–924. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources